4
Shared Docs
4
Same-Page
4 / 5
Mentions
in the Important Disclosures section above. India: For private circulation only, not for sale. Pakistan: For private circulation only, not for sale. New Zealand: This material is issued and distributed by JPMSAL in New Zealand only to persons whose principal business is the investment of money or who, in the
erage universe. If it does not appear in the Ira runt Disclosures section of this report, the cettifying analyst's coverage universe can be found on M. Morgan's research website, Coverage Universe: Schott, Christopher: AbbVie (ABBV), Actavis plc (ACT), Allergan (AGN), Amarin Corporation (AMRN), Bristol-Mye
y-14 OW 57.11 64.00 4 EFTA00306886 Chris Schott. CFA North America Equity Research 1-21 622-5676 02 June 2014 J.P.Morgan The chart(s) show M. Morgan's continuing coverage of the stocks; the current analysts may or may not have covered it over the entire riot M. Morgan ratings or designations: OW -
in the Important Disclosures section above. India: For private circulation only, not for sale. Pakistan: For private circulation only, not for sale. New Zealand: This material is issued and distributed by JPMSAL in New Zealand only to persons whose principal business is the investment of money or who, in the
OW 72.67 85.00 18-0ec-13 OW 73.59 100.00 EFTA00300342 Coon Ktorerom North America Equity Research 22 May 2014 J.RMorgan The chart(s) show M. Morgan's continuing coverage of the stocks; the current analysts may or may not have covered it over the entire period. J.P. Morgan ratings or designations:
in the Important Disclosures section above. India: For private circulation only, not for sale. Pakistan: For private circulation only, not for sale. New Zealand: This material is issued and distributed by JPMSAL in New Zealand only to persons whose principal business is the investment of money or who, in the
), and Underwei ht (over the next three months, the recommended risk position is expected to underperform the relevant index, sector, or benchmark). M. Morgan's Emerging Market research uses a rating of Markenveight, which is equivalent to a Neutral rating. Valuation & Methodology: In M. Morgan's credit res
n by t Morgan Securities (Taiwan) Limited. India: For private circulation only. not for sale. Pakistan: For private circulation only, not for sale. New Zealand: This material is issued and distributed by JPMSAL in New Zealand only to persons whose principal business is the investment of money or who, in the
4 OW 57.11 64.00 10-Oct-14 OW 59.21 66.00 20-Jan-15 OW 63.03 68.00 21-Sep-15 OW 52.13 65.00 30-Sep-15 OW 49.39 66.00 The chart(s) show M. Morgan's continuing coverage of the stocks; the current analysts may or may not have covered it over the entire M. Morgan ratings or designations: OW Overwei
Entities connected to both New Zealand and M. Morgan's

Malaysia
LOCATION
Bloomberg L.P.
ORGANIZATION
Philippines
LOCATION
Condoleezza Rice
PERSON
Frankfurt
LOCATIONthe Mexican Stock Exchange
ORGANIZATIONJapan Investment Advisers Association
ORGANIZATION
Bangkok
LOCATIONthe Securities and Exchange Commission
ORGANIZATIONthe Capital Market Authority
ORGANIZATION
Saudi Arabia
LOCATION
JPMorgan Chase
ORGANIZATIONthe Securities and Futures Commission
ORGANIZATION
Mumbai
LOCATIONKanto Local Finance Bureau
ORGANIZATIONthe Securities Commission
ORGANIZATION
the Ministry of Finance
ORGANIZATIONthe Indonesia Stock Exchange
ORGANIZATIONThe Financial Futures Association of Japan
ORGANIZATIONthe Stock Exchange of Thailand
ORGANIZATION